CRISPR-Cas9: Gene Technology’s Sharpest Tool
dc.contributor.author | Dang, Mary | |
dc.contributor.author | Angers, Kelsey L | |
dc.contributor.author | Roy, Annastasia | |
dc.contributor.author | Roma, Rebecca A | |
dc.contributor.author | Brown, Damon L | |
dc.contributor.author | Muleta, Mekdelawit | |
dc.contributor.author | Ginegaw, Alexys | |
dc.contributor.other | Anderson, Mary | |
dc.date.accessioned | 2021-03-19T16:45:14Z | |
dc.date.available | 2021-03-19T16:45:14Z | |
dc.date.issued | 2021 | |
dc.description | Creative Arts and Research Symposium | |
dc.description | Creative Arts and Research Symposium | en_US |
dc.description.abstract | In 2020, the Nobel Prize in Chemistry was awarded to Emmanuelle Charpentier and Jennifer A. Doudna for the discovery of a gene-editing system, CRISPR-Cas9, with the power to change the very fabric of our existence. CRISPR-Cas9 allows researchers to reconstruct DNA of living cells with the highest degree of flexibility and precision. Originating from an ancient defense mechanism in archaea bacteria, CRISPR-Cas9 has been effectively used to induce targeted mutations in multiple genes, create conditional alleles, and generate endogenic tagged proteins. This method differs from other geneediting techniques; it is low-cost and reduces the process from a number of years to a matter of weeks. Today, CRISPR-Cas9 is utilized in fields ranging from agriculture to medicine. However, in gaining access to such a powerful genetic tool, serial bioethical concerns were brought to the forefront within genome editing. Here, we discuss the various applications of CRISPR-Cas9 technology and ethical issues related. | |
dc.description.department | Chemistry & Biochemistry | |
dc.identifier.uri | https://hdl.handle.net/11274/12794 | |
dc.language.iso | en_US | en_US |
dc.title | CRISPR-Cas9: Gene Technology’s Sharpest Tool | en_US |
dc.type | Poster | en_US |